Avity Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.5M Sell
234,226
-2,817
-1% -$657K 3.79% 7
2026
Q1
$57.9M Sell
237,043
-10,077
-4% -$2.35M 4.22% 2
2025
Q4
$51.1M Sell
247,120
-6,205
-2% -$1.23M 3.59% 8
2025
Q3
$47M Sell
253,325
-1,038
-0.4% -$178K 3.3% 8
2025
Q2
$38.9M Buy
254,363
+12,709
+5% +$1.95M 2.89% 16
2025
Q1
$40.1M Buy
241,654
+3,349
+1% +$524K 3.24% 11
2024
Q4
$34.5M Sell
238,305
-3,912
-2% -$606K 2.7% 17
2024
Q3
$39.3M Buy
242,217
+1,498
+0.6% +$239K 3.06% 19
2024
Q2
$35.2M Sell
240,719
-1,014
-0.4% -$151K 2.84% 21
2024
Q1
$38.2M Sell
241,733
-15,582
-6% -$2.48M 3.17% 15
2023
Q4
$40.3M Buy
257,315
+2,281
+0.9% +$350K 3.61% 9
2023
Q3
$39.7M Sell
255,034
-2,880
-1% -$475K 3.97% 5
2023
Q2
$42.7M Buy
257,914
+3,179
+1% +$513K 3.95% 2
2023
Q1
$39.5M Buy
254,735
+182
+0.1% +$29.4K 3.84% 5
2022
Q4
$45M Sell
254,553
-3,261
-1% -$563K 4.6% 2
2022
Q3
$42.1M Sell
257,814
-4,397
-2% -$744K 4.57% 2
2022
Q2
$46.5M Sell
262,211
-2,157
-0.8% -$384K 4.78% 2
2022
Q1
$46.9M Buy
264,368
+1,810
+0.7% +$308K 4.11% 4
2021
Q4
$44.9M Buy
262,558
+6,118
+2% +$1M 3.5% 9
2021
Q3
$41.4M Buy
256,440
+2,273
+0.9% +$388K 3.49% 8
2021
Q2
$41.9M Buy
254,167
+3,228
+1% +$534K 3.54% 8
2021
Q1
$41.2M Buy
250,939
+1,000
+0.4% +$162K 3.74% 4
2020
Q4
$39.3M Buy
249,939
+11,606
+5% +$1.71M 3.75% 5
2020
Q3
$35.5M Buy
238,333
+2,371
+1% +$351K 3.7% 6
2020
Q2
$33.2M Sell
235,962
-632
-0.3% -$92.1K 3.73% 6
2020
Q1
$31M Sell
236,594
-2,930
-1% -$416K 4.32% 3
2019
Q4
$34.9M Buy
239,524
+4,637
+2% +$629K 3.86% 6
2019
Q3
$30.4M Sell
234,887
-245
-0.1% -$32.3K 3.66% 8
2019
Q2
$32.7M Sell
235,132
-436
-0.2% -$60.4K 3.89% 4
2019
Q1
$32.9M Sell
235,568
-340
-0.1% -$45.5K 3.99% 4
2018
Q4
$30.4M Sell
235,908
-1,436
-0.6% -$200K 4.24% 2
2018
Q3
$32.8M Buy
237,344
+496
+0.2% +$65.9K 3.89% 3
2018
Q2
$28.7M Buy
236,848
+3,393
+1% +$423K 3.64% 9
2018
Q1
$29.9M Buy
233,455
+1,400
+0.6% +$189K 3.91% 6
2017
Q4
$32.4M Buy
232,055
+1,545
+0.7% +$215K 4.1% 3
2017
Q3
$30M Sell
230,510
-975
-0.4% -$129K 3.99% 3
2017
Q2
$30.6M Buy
231,485
+725
+0.3% +$92.5K 4.16% 2
2017
Q1
$28.7M Sell
230,760
-1,068
-0.5% -$128K 4.03% 3
2016
Q4
$26.7M Sell
231,828
-1,126
-0.5% -$130K 4.02% 2
2016
Q3
$27.9M Sell
232,954
-7,121
-3% -$864K 4.31% 2
2016
Q2
$29.1M Sell
240,075
-1,609
-0.7% -$183K 4.67% 1
2016
Q1
$26.6M Sell
241,684
-5,119
-2% -$530K 4.28% 2
2015
Q4
$25.4M Buy
246,803
+2,386
+1% +$240K 3.99% 3
2015
Q3
$23.9M Buy
244,417
+10,805
+5% +$1.05M 3.86% 5
2015
Q2
$22.8M Buy
233,612
+4,791
+2% +$480K 3.58% 10
2015
Q1
$22.9M Buy
228,821
+1,851
+0.8% +$188K 3.64% 6
2014
Q4
$23.7M Buy
226,970
+1,866
+0.8% +$197K 3.81% 3
2014
Q3
$24M Sell
225,104
-1,456
-0.6% -$151K 4.08% 2
2014
Q2
$23.7M Sell
226,560
-6,144
-3% -$621K 4.06% 2
2014
Q1
$22.9M Sell
232,704
-1,767
-0.8% -$164K 4.28% 3
2013
Q4
$21.5M Sell
234,471
-10,625
-4% -$979K 4.1% 4
2013
Q3
$21.2M Sell
245,096
-15,281
-6% -$1.37M 4.4% 1
2013
Q2
$22.4M Buy
+260,377
New +$22.1M 4.79% 1

Other funds holding JNJ

Avity Investment Management's JNJ Position: Q2 2026 in Review

Avity Investment Management reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q2 2026, selling an estimated $657K and leaving 234,226 shares worth $59.5M. The position accounts for 3.79% of the portfolio, ranked #7.

Avity Investment Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Avity Investment Management held 234,226 shares of Johnson & Johnson worth $59.5M as of Q2 2026.
  • Avity Investment Management sold 2,817 Johnson & Johnson shares in Q2 2026, an estimated $657K.
  • Johnson & Johnson made up 3.79% of Avity Investment Management's portfolio in Q2 2026, its #7 holding.
  • Avity Investment Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Avity Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.